A Novel Drug for Borderline Personality Disorder

Clinical trial NCT02097706 · RECRUITING

Trial details

NCT number: NCT02097706
Sponsor: The Alfred
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Borderline Personality Disorder

Start date: 2015-01-01
Primary completion: 2025-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.